Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer.
Saved in:
| Title: | Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer. |
|---|---|
| Authors: | Beutel AK; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany., Calderon S; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA., Nghiem E; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA., Gulay K; Department of Surgery, University of California San Diego, La Jolla, USA., Santana LPS; West of Scotland HPB Unit, Glasgow Royal Infirmary, Glasgow G61 1QH, UK.; School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK., Zimmer E; Institute of Molecular Oncology and Stem Cell Biology, University Hospital Ulm, Ulm, Germany., Singh R; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA., Anaraki C; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA., Yousefian N; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA., Allgöwer C; Institute of Molecular Oncology and Stem Cell Biology, University Hospital Ulm, Ulm, Germany., Tong G; Department of Pharmaceutical Sciences University of California Irvine, Irvine, USA., Geller C; Department of Developmental and Cell Biology University of California Irvine, Irvine, USA., Chao A; Department of Biological Chemistry University of California Irvine, Irvine, USA., Juarez D; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA., Seufferlein T; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany., Muir A; Ben May Department for Cancer Research University of Chicago, Chicago, USA., Jang C; Department of Biological Chemistry University of California Irvine, Irvine, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, USA., Edinger AL; Department of Pharmaceutical Sciences University of California Irvine, Irvine, USA.; Department of Developmental and Cell Biology University of California Irvine, Irvine, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, USA., Seldin M; Department of Biological Chemistry University of California Irvine, Irvine, USA., Martinez TF; Department of Pharmaceutical Sciences University of California Irvine, Irvine, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, USA., Kleger A; Institute of Molecular Oncology and Stem Cell Biology, University Hospital Ulm, Ulm, Germany.; Division of Interdisciplinary Pancreatology, Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany., Chang DK; West of Scotland HPB Unit, Glasgow Royal Infirmary, Glasgow G61 1QH, UK.; School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK., Tiriac H; Department of Surgery, University of California San Diego, La Jolla, USA., Valerin JB; Chao Family Comprehensive Cancer Center, University of California Irvine, USA.; Department of Medicine, Division of Hematology and Oncology, University of California Irvine, Orange, USA., Fruman DA; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, USA., Halbrook CJ; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2025 Sep 20. Date of Electronic Publication: 2025 Sep 20. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41000736 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Beutel+AK%22">Beutel AK</searchLink>; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Calderon+S%22">Calderon S</searchLink>; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Nghiem+E%22">Nghiem E</searchLink>; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Gulay+K%22">Gulay K</searchLink>; Department of Surgery, University of California San Diego, La Jolla, USA.<br /><searchLink fieldCode="AU" term="%22Santana+LPS%22">Santana LPS</searchLink>; West of Scotland HPB Unit, Glasgow Royal Infirmary, Glasgow G61 1QH, UK.; School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.<br /><searchLink fieldCode="AU" term="%22Zimmer+E%22">Zimmer E</searchLink>; Institute of Molecular Oncology and Stem Cell Biology, University Hospital Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Singh+R%22">Singh R</searchLink>; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Anaraki+C%22">Anaraki C</searchLink>; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Yousefian+N%22">Yousefian N</searchLink>; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Allgöwer+C%22">Allgöwer C</searchLink>; Institute of Molecular Oncology and Stem Cell Biology, University Hospital Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Tong+G%22">Tong G</searchLink>; Department of Pharmaceutical Sciences University of California Irvine, Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Geller+C%22">Geller C</searchLink>; Department of Developmental and Cell Biology University of California Irvine, Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Chao+A%22">Chao A</searchLink>; Department of Biological Chemistry University of California Irvine, Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Juarez+D%22">Juarez D</searchLink>; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Seufferlein+T%22">Seufferlein T</searchLink>; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Muir+A%22">Muir A</searchLink>; Ben May Department for Cancer Research University of Chicago, Chicago, USA.<br /><searchLink fieldCode="AU" term="%22Jang+C%22">Jang C</searchLink>; Department of Biological Chemistry University of California Irvine, Irvine, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Edinger+AL%22">Edinger AL</searchLink>; Department of Pharmaceutical Sciences University of California Irvine, Irvine, USA.; Department of Developmental and Cell Biology University of California Irvine, Irvine, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Seldin+M%22">Seldin M</searchLink>; Department of Biological Chemistry University of California Irvine, Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Martinez+TF%22">Martinez TF</searchLink>; Department of Pharmaceutical Sciences University of California Irvine, Irvine, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Kleger+A%22">Kleger A</searchLink>; Institute of Molecular Oncology and Stem Cell Biology, University Hospital Ulm, Ulm, Germany.; Division of Interdisciplinary Pancreatology, Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Chang+DK%22">Chang DK</searchLink>; West of Scotland HPB Unit, Glasgow Royal Infirmary, Glasgow G61 1QH, UK.; School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.<br /><searchLink fieldCode="AU" term="%22Tiriac+H%22">Tiriac H</searchLink>; Department of Surgery, University of California San Diego, La Jolla, USA.<br /><searchLink fieldCode="AU" term="%22Valerin+JB%22">Valerin JB</searchLink>; Chao Family Comprehensive Cancer Center, University of California Irvine, USA.; Department of Medicine, Division of Hematology and Oncology, University of California Irvine, Orange, USA.<br /><searchLink fieldCode="AU" term="%22Fruman+DA%22">Fruman DA</searchLink>; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, USA.<br /><searchLink fieldCode="AU" term="%22Halbrook+CJ%22">Halbrook CJ</searchLink>; Department of Molecular Biology and Biochemistry University of California Irvine, Irvine, USA.; Chao Family Comprehensive Cancer Center, University of California Irvine, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2025 Sep 20. <i>Date of Electronic Publication: </i>2025 Sep 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Preprint – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41000736 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1101/2025.09.19.675739 Languages: – Code: eng Text: English Titles: – TitleFull: Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Beutel AK – PersonEntity: Name: NameFull: Calderon S – PersonEntity: Name: NameFull: Nghiem E – PersonEntity: Name: NameFull: Gulay K – PersonEntity: Name: NameFull: Santana LPS – PersonEntity: Name: NameFull: Zimmer E – PersonEntity: Name: NameFull: Singh R – PersonEntity: Name: NameFull: Anaraki C – PersonEntity: Name: NameFull: Yousefian N – PersonEntity: Name: NameFull: Allgöwer C – PersonEntity: Name: NameFull: Tong G – PersonEntity: Name: NameFull: Geller C – PersonEntity: Name: NameFull: Chao A – PersonEntity: Name: NameFull: Juarez D – PersonEntity: Name: NameFull: Seufferlein T – PersonEntity: Name: NameFull: Muir A – PersonEntity: Name: NameFull: Jang C – PersonEntity: Name: NameFull: Edinger AL – PersonEntity: Name: NameFull: Seldin M – PersonEntity: Name: NameFull: Martinez TF – PersonEntity: Name: NameFull: Kleger A – PersonEntity: Name: NameFull: Chang DK – PersonEntity: Name: NameFull: Tiriac H – PersonEntity: Name: NameFull: Valerin JB – PersonEntity: Name: NameFull: Fruman DA – PersonEntity: Name: NameFull: Halbrook CJ IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 09 Text: 2025 Sep 20 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |